title: Intravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion: a pilot study.
abstract: OBJECTIVE
  To evaluate treatment of macular oedema due to branch retinal vein occlusion (BRVO) with intravitreal triamcinolone acetonide.
  
  
  METHODS
  In a prospective case series, nine patients with macular oedema due to BRVO received an intravitreal injection of 4 mg triamcinolone acetonide. Examination included best-corrected visual acuity (BCVA) for distance and reading, intraocular pressure (IOP) measurement, fluorescein angiography and high resolution imaging by optical coherence tomography, preoperatively and at 1 week, 1 month, 3 and 6 months postoperatively.
  
  
  RESULTS
  Preoperative mean BCVAs were 1.3 +/- 0.8 for distance vision, and 1.1 +/- 0.3 for reading acuity, respectively. A significant improvement in reading acuity was observed until 1 month (0.7 +/- 0.4, p = 0.02). No significant reduction in mean macular thickness was observed.
  
  
  CONCLUSIONS
  Intravitreal injection of triamcinolone acetonide led to a significant improvement in mean VA in patients with macular oedema due to BRVO. However, the significant effect was not permanent and persisted for only 1 month.
authors.affiliation: Department of Ophthalmology, Medical University of Vienna, Vienna, Austria. katharina.krepler@meduniwien.ac.at
authors.forename: Katharina
authors.initials: K
authors.lastname: Krepler
authors.forename: Erdem
authors.initials: E
authors.lastname: Ergun
authors.forename: Stefan
authors.initials: S
authors.lastname: Sacu
authors.forename: Sibylla
authors.initials: S
authors.lastname: Richter-Müksch
authors.forename: Julia
authors.initials: J
authors.lastname: Wagner
authors.forename: Michael
authors.initials: M
authors.lastname: Stur
authors.forename: Andreas
authors.initials: A
authors.lastname: Wedrich
mesh_terms: D000368:Aged; D005451:Fluorescein Angiography; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007267:Injections; D007429:Intraocular Pressure / Q000502:physiology; D008269:Macular Edema / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D010865:Pilot Projects; D011446:Prospective Studies; D012170:Retinal Vein Occlusion / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D041623:Tomography, Optical Coherence; D014222:Triamcinolone Acetonide / Q000008:administration & dosage / Q000627:therapeutic use*; D014792:Visual Acuity / Q000502:physiology; D014822:Vitreous Body
chemical_list: D005938:Glucocorticoids; D014222:Triamcinolone Acetonide